Brooks Nader reveals ongoing addiction to weight-loss drugs despite family intervention on reality show after sisters found ...

Brooks Nader opened up about her use of GLP-1 weight loss drugs, admitting that her "career took off" when she first starting ...

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...

Novo Nordisk’s closest competitor, Eli Lilly, continues to challenge its dominance in the weight-loss drug market. Eli Lilly, ...

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...

Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...

Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them is Pfizer; in September that company announced it would acquire Metsera, a ...

Ahead of a reported White House deal meant to lower the cost of obesity drugs like Wegovy, Novo said “intensifying ...

Among over 151,000 patients, use of GLP-1 drugs was linked to a lower risk of death compared with no use (adjusted HR 0.77, 95% CI 0.70-0.85, P <0.001), reported Babak J. Orandi, MD, PhD, MSc, of NYU ...

Findings from a recent study found that GLP-1 medications are reshaping retail habits, as nearly 70% of users still buy their ...